Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2-Reference-Cited by-同舟云学术

Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2

Author:

Thakur Aarzoo¹²,Tan Shawn Pei Feng¹²,Chan James Chun Yip¹²³

Affiliation:

1. Innovations in Food and Chemical Safety Agency for Science, Technology, and Research Singapore City Singapore

2. Skin Research Institute of Singapore Agency for Science, Technology, and Research Singapore City Singapore

3. Singapore Institute of Food and Biotechnology Innovation Agency for Science, Technology, and Research Singapore City Singapore

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference44 articles.

1. World Health Organization Coronavirus disease 2019 Situation Report 167. (2020) .

2. Centre for Drug Evaluation and Research FDA Kaletra Clinical Pharmacology and Biopharmaceutical Review. (2000) .

5. WHO “Solidarity” clinical trial for COVID‐19 treatments. (2020) .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献